The Several Measures to Support the Development of Innovative Pharmaceutical Devices in Hainan Province (hereinafter referred to as the "Several Measures") have recently been introduced. The "Several Measures" are expected to further stimulate the innovation capabilities of enterprises and promote the wider application of innovative products in clinical practice, while improving the diversified supply of innovative drugs and ensuring that the public enjoys fair and accessible medical services. On the 17th, the Hainan Provincial Information Office held a press conference to interpret the policies of "Several Measures". Several Measures to Improve the Mechanism for Price Formation of Innovative Medical Devices. By establishing a mechanism for the formation of initial pricing for newly approved innovative drugs and devices entering the market, optimizing the pricing and conversion mechanism for new medical services during the trial period, encouraging medical institutions and enterprises to negotiate independently on procurement platforms, and following the principle that the price of innovative drugs and devices is determined by the market, the government plays a guiding role in completing the mechanism for the formation of innovative drug and device prices. According to the "Several Measures", Hainan will improve the efficiency of the use of medical insurance funds by establishing an efficient and effective medical insurance payment mechanism. At the same time, measures such as supporting the direct online procurement of innovative drugs, prioritizing the compatibility of existing price items to support the innovative application of drugs, and opening up green channels to accelerate the review speed of new medical service price items will be taken to improve the speed of innovative drugs entering clinical applications. Li Wenxiu, Director of the Hainan Provincial Medical Security Bureau, stated that the bureau will work together with the Hainan Provincial Health Commission and other departments to actively promote the timely application of innovative drugs and technologies for insurance, in accordance with the principles of caring for the people and encouraging innovation, and strive to reduce the burden of medical expenses on patients. For example, conducting value evaluations of innovative pharmaceutical devices through real-world data, exploring the use of evaluation results as decision-making reference evidence for catalog adjustments, centralized procurement of medical consumables for drugs, and evaluation of national negotiated drugs; Through the normalization of face-to-face activities between medical insurance and medical enterprises, we provide guidance on national medical insurance negotiation access policies for pharmaceutical enterprises, support the participation of innovative drugs in national negotiations, and timely inclusion in the medical insurance catalog. In recent years, commercial health insurance in Hainan Province has developed rapidly. Li Wenxiu introduced that the bureau will promote the formation of a diversified payment mechanism for innovative drugs and devices, strengthen the supply of commercial insurance, promote the sharing of data between basic medical insurance platforms and commercial insurance companies, support commercial insurance companies in developing inclusive commercial health insurance products and services covering innovative drugs and devices, promote the "one-stop" and "one window" settlement of basic medical insurance and commercial health insurance, and improve the accessibility and affordability of innovative drugs and devices, Form an effective supplement to basic medical insurance. (Lixin News Agency) (Reporter Zhang Qianyi)